NASDAQ:NUZE NuZee (NUZE) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free NUZE Stock Alerts $1.65 -0.03 (-1.79%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range$1.63▼$1.6950-Day Range$1.17▼$2.4452-Week Range$1.13▼$12.39Volume6,209 shsAverage Volume1.43 million shsMarket Capitalization$2.15 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get NuZee alerts: Email Address Ad Weiss RatingsOn June 10, Nvidia makes its next big moveA small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. About NuZee Stock (NASDAQ:NUZE)NuZee, Inc., together with its subsidiaries, manufactures, packs, and sells single-serve pour-over coffee and tea bag-style coffee for coffee roasters and food service companies in North America and South Korea. The company sells its products under Coffee Blenders, Twin Peaks, DRIPKIT, and Stone Brewing brand names. NuZee, Inc. was incorporated in 2011 and is headquartered in Vista, California.Read More NUZE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NUZE Stock News HeadlinesMay 24, 2024 | morningstar.comNuzee Inc NUZEMay 20, 2024 | msn.comHims & Hers Health and BTC Digital among Consumer Staples moversMay 6, 2024 | investorplace.comNUZE Stock Earnings: Nuzee Misses EPS, Misses Revenue for Q1 2024May 2, 2024 | finance.yahoo.comNuZee, Inc. Announces Completion of Private Placement of Convertible Note and WarrantsMay 2, 2024 | prnewswire.comNuZee, Inc. Announces Completion of Private Placement of Convertible Note and WarrantsApril 14, 2024 | finance.yahoo.comHot Drinks Packaging Market Size is projected to reach USD 16.10 billion by 2031, growing at a CAGR of 4.12%: Straits ResearchApril 11, 2024 | prnewswire.comNuZee, Inc. Announces NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)March 1, 2024 | finanznachrichten.deNuZee, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)February 29, 2024 | prnewswire.comNuZee, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)February 27, 2024 | finance.yahoo.comBTDR Apr 2024 2.500 putFebruary 14, 2024 | finance.yahoo.comNuZee, Inc. Announces Extension for Filing of Form 10-QFebruary 14, 2024 | prnewswire.comNuZee, Inc. Announces Extension for Filing of Form 10-QJanuary 26, 2024 | finance.yahoo.comNuZee, Inc. Announces Receipt of NASDAQ NotificationJanuary 17, 2024 | finance.yahoo.comNuZee, Inc. Reports Full-Year Fiscal 2023 Financial ResultsDecember 29, 2023 | finance.yahoo.comNuZee, Inc. Announces Delay in Filing Form 10-KDecember 13, 2023 | msn.comStocks Tread Water Before the Open as Fed Rate Decision Looms, U.S. PPI Data in FocusDecember 13, 2023 | msn.comStocks Tread Water Before the Open as Investors Await Fed Rate Decision and U.S. PPI DataDecember 12, 2023 | marketwatch.comNuZee Names CFO Randell Weaver President, chief operating officer.December 12, 2023 | finance.yahoo.comNuZee, Inc. Appoints Randell Weaver as President and Chief Operating OfficerDecember 5, 2023 | finance.yahoo.comNuZee, Inc. Announces Full Exercise and Closing of Over-Allotment Option in Connection with its Underwritten Public OfferingOctober 20, 2023 | finance.yahoo.comNuZee Announces Closing of $1.275 Million Underwritten Public Offering of Common StockOctober 18, 2023 | benzinga.comWhy NuZee Stock Is Down Over 40% WednesdayOctober 18, 2023 | marketwatch.comNuZee Shares Slide to 52-Week Low After Offering PricedOctober 18, 2023 | marketwatch.comNuZee Shares Slide Premarket on Planned Public OfferingOctober 18, 2023 | msn.comNuZee stock plummets on pricing of $1.275M common stock offeringSee More Headlines Receive NUZE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NuZee and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/06/2024Today5/31/2024Next Earnings (Estimated)8/09/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Miscellaneous retail Sub-IndustryN/A Current SymbolNASDAQ:NUZE CUSIPN/A CIK1527613 Webwww.mynuzee.com Phone(760) 295-2408FaxN/AEmployees33Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($9.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,750,000.00 Net Margins-247.67% Pretax Margin-247.67% Return on Equity-537.84% Return on Assets-181.77% Debt Debt-to-Equity RatioN/A Current Ratio0.56 Quick Ratio0.60 Sales & Book Value Annual Sales$3.35 million Price / Sales0.64 Cash FlowN/A Price / Cash FlowN/A Book Value($0.44) per share Price / Book-3.75Miscellaneous Outstanding Shares1,300,000Free Float941,000Market Cap$2.15 million OptionableNot Optionable Beta1.51 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Masateru Higashida (Age 53)Chairman, CEO ,Treasurer & Secretary Comp: $300kMr. Randell L. Weaver (Age 66)President, COO & CFO Ms. Shana Bowman (Age 47)Controller Key CompetitorsJeffs' BrandsNASDAQ:JFBRParty City HoldcoNYSE:PRTYAcorn InternationalNYSE:ATVZAGGNASDAQ:ZAGGFirstCashNASDAQ:FCFSView All CompetitorsInsidersMasateru HigashidaSold 500 sharesTotal: $2,580.00 ($5.16/share)Masateru HigashidaSold 1,200 sharesTotal: $8,796.00 ($7.33/share)View All Insider Transactions NUZE Stock Analysis - Frequently Asked Questions Should I buy or sell NuZee stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NuZee in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NUZE shares. View NUZE analyst ratings or view top-rated stocks. How have NUZE shares performed in 2024? NuZee's stock was trading at $2.54 at the start of the year. Since then, NUZE shares have decreased by 35.0% and is now trading at $1.65. View the best growth stocks for 2024 here. Are investors shorting NuZee? NuZee saw a drop in short interest in May. As of May 15th, there was short interest totaling 70,600 shares, a drop of 62.1% from the April 30th total of 186,200 shares. Based on an average trading volume of 512,200 shares, the days-to-cover ratio is currently 0.1 days. Currently, 6.6% of the shares of the stock are short sold. View NuZee's Short Interest. When is NuZee's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, August 9th 2024. View our NUZE earnings forecast. How were NuZee's earnings last quarter? NuZee, Inc. (NASDAQ:NUZE) posted its quarterly earnings data on Monday, May, 6th. The company reported ($1.84) earnings per share (EPS) for the quarter. The company had revenue of $1.35 million for the quarter. NuZee had a negative trailing twelve-month return on equity of 537.84% and a negative net margin of 247.67%. When did NuZee's stock split? NuZee's stock reverse split before market open on Thursday, December 29th 2022. The 1-35 reverse split was announced on Thursday, December 29th 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What other stocks do shareholders of NuZee own? Based on aggregate information from My MarketBeat watchlists, some companies that other NuZee investors own include Adaptimmune Therapeutics (ADAP), Acasti Pharma (ACST), Acorda Therapeutics (ACOR), ACI Worldwide (ACIW), Albertsons Companies (ACI), Achieve Life Sciences (ACHV), Acer Therapeutics (ACER), Abiomed (ABMD) and ARCA biopharma (ABIO). How do I buy shares of NuZee? Shares of NUZE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NUZE) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyMAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…AltimetryUnlock Explosive Gains with This Defense StockBehind the MarketsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin Pro Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuZee, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
